Alopecia Market Size Worth USD 5,250.8 Million by 2027 | CAGR of 8.9%: Emergen Research

VANCOUVER, BC, Oct. 13, 2020 /PRNewswire/ -- The Global Alopecia Market is projected to be worth USD 5,250.8 Million by 2027, according to a current analysis by Emergen Research. The alopecia market is projected to experience rapid growth by the year 2027. The rising occurrence of alopecia is a significant factor driving the growth of the market. For instance, alopecia areata, a chronic, autoimmune disorder that affects growing hair follicles resulting in nonscarring focal hair loss, has global prevalence. The disease's likely occurrence is about 0.001% of the population and has a lifetime risk of around 2.0%. It may occur in people of all ages, including children and adults, and at more or less the same rate in the male and female population.

Emergen_Research_Logo

Growing trends in hair fashion put a lot of unwanted stress on the hair follicles, leading to traumatic alopecia, in turn, driving the market growth. This type of alopecia is caused by hairdressing practices such as cornrowing or tight braiding leading to hair pull, hair damage with strong chemicals comprising hair coloring, bleaching, straightening, and permanent waves, or application of extreme heat, for instance, with a hot roller.

Additionally, various chronic disorders and genetic diseases may be causative of hair loss/alopecia in people. Male pattern baldness, a hereditary cause of hair loss, may be triggered at any point in a man's life, including adolescence. Moreover, some individuals suffer from trichotillomania (a rare psychiatric condition) in which compulsive twisting and pulling of hair can lead to bald spots.

Request free sample of this research report at: https://www.emergenresearch.com/request-sample/175

Key Highlights From The Report

  • In January 2020, Revian announced that it had received a patent by the U.S. Patent & Trademark Office (USPTO) for the application of proprietary color light combinations for regenerating living body tissues, such as hair.
  • Androgenetic alopecia is likely to grow at the fastest rate in the period 2020-2027. It is a commonly occurring hair loss in the global population. In the case of men, it is also referred to as male-pattern baldness.
  • Alopecia totalis causes total hair loss on the scalp and is considered an advanced form of alopecia areata responsible for round hair loss patches.
  • PCO (Polycystic Ovary Syndrome) is responsible for androgenic alopecia in females worldwide, with an anticipated 20.0% of females witnessing the condition before menopause and around 40.0% post-menopause.
  • The OTC (over-the-counter) availability of alopecia treatment drugs is fueled by the increasing attempts to provide easy therapeutic accessibility and the necessity for affordable treatment.
  • The market in the Asia Pacific region is projected to grow at the fastest rate of 10.0% in the forecast period due to the increasing incidence of chronic disorders, growing awareness among the population, especially in the younger generation, and a rise in the level of disposable income.
  • Key participants include Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc., Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Concert Pharmaceuticals Inc., GlaxoSmithKline PLC, Aclaris Therapeutics Inc., and HCell Inc., among others.

To get leading market solutions, visit the link below:

https://www.emergenresearch.com/industry-report/alopecia-market

Emergen Research has segmented the global alopecia market on the basis of type, application, end-users, distribution channel, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Alopecia Areata
  • Androgenetic Alopecia
  • Alopecia Totalis
  • Traction Alopecia
  • Cicatricle Alopecia
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Male
  • Female

End-Users Outlook (Revenue, USD Billion; 2017-2027)

  • Dermatology Clinics
  • Homecare Settings
  • Others

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)

  • Prescription
  • OTC (Over-the-Counter)

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K
    • France
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA

Find more similar research insights by Emergen Research:

Inhalation and Nasal Spray Market By Application (Asthma, COPD, Allergic Rhinitis, Others), By Drug Type (Corticosteroids, Bronchodilators, Antihistamines, Decongestant Sprays, Others) and By Regions Forecasts to 2027

Jet Lag Therapy Market By Product (Prescription Drugs, Melatonin, Herbal & Natural Products, Medical Devices, Others), By Distribution Channel (Over the Counter, Online), By End User (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers, Others) and By Regions Forecasts to 2027

Depression Treatment Market By Drug Type (Antidepressants, Antipsychotics) By Application (Major Depressive Disorder (MDD), Bipolar Disorder), By End-User (Hospitals, NGOs, Mental Health Centers), By Distribution Channel, and By Region, Forecasts to 2027

Research Antibodies Market By Market By Product, By Antibody Type (Monoclonal, Polyclonal), By Technology, By Application, By End-Users (Pharmaceutical & Biopharmaceutical Firms, Academic & Research Institutes, Contract Research Organizations), Forecasts to 2027

Diabetic Care Market By Devices (Monitoring Devices, Insulin Pumps, Syringes and Cartridges, Disposable Pens, Jet Injectors), By Distribution Channel (Hospital, Retail and Online Pharmacies, Diabetic Clinics, Others), By End User (Hospitals, Homecare, Diagnostic Centers) and By Regions Forecasts to 2027

Brachytherapy Market By Type, By Application, By End-Users, Forecasts to 2027

About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies. 

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Read full Press Release at: https://www.emergenresearch.com/press-release/global-alopecia-market 

 

Cision View original content:http://www.prnewswire.com/news-releases/alopecia-market-size-worth-usd-5-250-8-million-by-2027--cagr-of-8-9-emergen-research-301151064.html

SOURCE Emergen Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.